ARSUF
Price
$20.03
Change
-$0.82 (-3.93%)
Updated
Oct 29 closing price
Capitalization
1.76B
AVCNF
Price
$0.20
Change
-$0.00 (-0.00%)
Updated
Aug 28 closing price
Capitalization
23.84M
Interact to see
Advertisement

ARSUF vs AVCNF

Header iconARSUF vs AVCNF Comparison
Open Charts ARSUF vs AVCNFBanner chart's image
Fagron SA
Price$20.03
Change-$0.82 (-3.93%)
Volume$425
Capitalization1.76B
Avicanna
Price$0.20
Change-$0.00 (-0.00%)
Volume$159.01K
Capitalization23.84M
ARSUF vs AVCNF Comparison Chart in %
Loading...
ARSUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AVCNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARSUF vs. AVCNF commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARSUF is a Hold and AVCNF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ARSUF: $20.03 vs. AVCNF: $0.20)
Brand notoriety: ARSUF and AVCNF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ARSUF: 100% vs. AVCNF: 239%
Market capitalization -- ARSUF: $1.76B vs. AVCNF: $23.84M
ARSUF [@Pharmaceuticals: Generic] is valued at $1.76B. AVCNF’s [@Pharmaceuticals: Generic] market capitalization is $23.84M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARSUF’s FA Score shows that 1 FA rating(s) are green whileAVCNF’s FA Score has 0 green FA rating(s).

  • ARSUF’s FA Score: 1 green, 4 red.
  • AVCNF’s FA Score: 0 green, 5 red.
According to our system of comparison, ARSUF is a better buy in the long-term than AVCNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARSUF’s TA Score shows that 1 TA indicator(s) are bullish while AVCNF’s TA Score has 5 bullish TA indicator(s).

  • ARSUF’s TA Score: 1 bullish, 0 bearish.
  • AVCNF’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ARSUF is a better buy in the short-term than AVCNF.

Price Growth

ARSUF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while AVCNF (@Pharmaceuticals: Generic) price change was +2.56% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.15%. For the same industry, the average monthly price growth was +68.06%, and the average quarterly price growth was +81.85%.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.15% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARSUF($1.76B) has a higher market cap than AVCNF($23.8M). AVCNF YTD gains are higher at: 0.542 vs. ARSUF (0.000). ARSUF has higher annual earnings (EBITDA): 171M vs. AVCNF (-1.47M). ARSUF has more cash in the bank: 89.3M vs. AVCNF (457K). AVCNF has less debt than ARSUF: AVCNF (73.5K) vs ARSUF (403M). ARSUF has higher revenues than AVCNF: ARSUF (919M) vs AVCNF (25.3M).
ARSUFAVCNFARSUF / AVCNF
Capitalization1.76B23.8M7,382%
EBITDA171M-1.47M-11,667%
Gain YTD0.0000.542-
P/E Ratio17.97N/A-
Revenue919M25.3M3,632%
Total Cash89.3M457K19,540%
Total Debt403M73.5K548,299%
FUNDAMENTALS RATINGS
ARSUF vs AVCNF: Fundamental Ratings
ARSUF
AVCNF
OUTLOOK RATING
1..100
4681
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
65
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
7263
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARSUF's Valuation (24) in the null industry is somewhat better than the same rating for AVCNF (65). This means that ARSUF’s stock grew somewhat faster than AVCNF’s over the last 12 months.

ARSUF's Profit vs Risk Rating (100) in the null industry is in the same range as AVCNF (100). This means that ARSUF’s stock grew similarly to AVCNF’s over the last 12 months.

ARSUF's SMR Rating (100) in the null industry is in the same range as AVCNF (100). This means that ARSUF’s stock grew similarly to AVCNF’s over the last 12 months.

AVCNF's Price Growth Rating (63) in the null industry is in the same range as ARSUF (72). This means that AVCNF’s stock grew similarly to ARSUF’s over the last 12 months.

AVCNF's P/E Growth Rating (100) in the null industry is in the same range as ARSUF (100). This means that AVCNF’s stock grew similarly to ARSUF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARSUFAVCNF
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
N/A
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
19%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
19%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
N/A
Bullish Trend 11 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 9 days ago
86%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ARSUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AVCNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OFSAX22.17N/A
N/A
Olstein Strategic Opportunities A
DVRPX17.97N/A
N/A
UBS US Dividend Ruler P2
VFAIX65.92N/A
N/A
Vanguard Financials Index Admiral
PIERX30.90N/A
N/A
Putnam International Equity R
ACAZX44.95N/A
N/A
Alger Capital Appreciation Z

ARSUF and

Correlation & Price change

A.I.dvisor tells us that ARSUF and CRDL have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARSUF and CRDL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARSUF
1D Price
Change %
ARSUF100%
N/A
CRDL - ARSUF
22%
Poorly correlated
-2.68%
AVCNF - ARSUF
12%
Poorly correlated
+3.32%
ALID - ARSUF
8%
Poorly correlated
N/A
BSPK - ARSUF
2%
Poorly correlated
N/A
BIOGY - ARSUF
2%
Poorly correlated
N/A
More

AVCNF and

Correlation & Price change

A.I.dvisor tells us that AVCNF and PRFX have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AVCNF and PRFX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVCNF
1D Price
Change %
AVCNF100%
+3.32%
PRFX - AVCNF
20%
Poorly correlated
-8.70%
ARSUF - AVCNF
12%
Poorly correlated
N/A
BSPK - AVCNF
9%
Poorly correlated
N/A
APNHY - AVCNF
7%
Poorly correlated
+1.42%
BKUH - AVCNF
5%
Poorly correlated
N/A
More